Table 1. Clinical patients’ characteristics.
Parameters | Overall populationn = 100 | Septicn = 37 (37%) | Non-Septicn = 63 (63%) | p value |
Age (years) | 37±17 | 35±16 | 38±17 | .34 * |
Male,% (n) | 73% (n = 73) | 81% (n = 30) | 68% (n = 43) | .24 ♦ |
ISS | 37±10 | 39±8 | 35±10 | .06 * |
Severe brain injury,% (n) | 38% (n = 38) | 57% (n = 21) | 27% (n = 17) | .006 ♦ |
Severe thoracic injury,% (n) | 74% (n = 74) | 62% (n = 23) | 81% (n = 51) | .07 ♦ |
SAPS II | 36.4±15.4 | 42.5±15.8 | 32.8±14.1 | .002 * |
Need for vasoactive support in emergency room,% (n) | 26% (n = 26) | 38% (n = 14) | 19% (n = 12) | .07 ♦ |
Prophylactic antibiotics administrated in emergency room,% (n) | 42% (n = 42) | 38% (n = 14) | 44% (n = 28) | .66 ♦ |
SOFA score | ||||
D1 | 4 [2]; [7] | 7 [4.25; 10] | 3[2]; [5] | <.0001 ‡ |
D2 | 4 [2]; [6] | 6[3.5; 10] | 2.5 [1]; [5] | <.0001 ‡ |
D3 | 3 [2]; [6] | 7 [3.5; 9] | 2 [1]; [3] | <.0001 ‡ |
D4 | 3 [1]; [5] | 5.5 [2.5; 8] | 2 [1]; [3] | <.0001 ‡ |
D5 | 2 [1]; [4] | 5 [1.5; 7.5] | 1 [1]; [3] | <.0001 ‡ |
D6 | 1 [1]; [4] | 4 [1.5; 7] | 1 [1]; [2] | <.0001 ‡ |
Shock (need for vasoactive drug on D1–2),% (n) | 35% (n = 35) | 59% (n = 22) | 21% (n = 13) | .0002 ♦ |
Mechanical ventilation (MV),% (n) | 66% (n = 66) | 89% (n = 33) | 52% (n = 33) | .0004 ♦ |
Duration of MV, days | 6 [3]; [12] | 10 [6]; [19] | 3 [2; 5.25] | <.0001 ‡ |
Massive transfusion required,% (n) | 32% (n = 32) | 40% (n = 15) | 27% (n = 17) | .24 ♦ |
Volume of global transfusion, ml | 900 [0; 3,050] | 1,800 [150; 4,300] | 0 [0; 2,700] | .02 ‡ |
Length of stay in ICU, days | 9.5 [6]; [15] | 15 [10.75; 24.25] | 7 [5; 10.75] | <.0001 ‡ |
Non-survivors at day 28,% (n) | 5% (n = 5) | 8% (n = 3) | 3% (n = 2) | .06 ♦ |
Parametric variables are expressed as mean ± standard deviation, and non-parametric variables as median (interquartile range) or frequencies.
*Independent samples t-test.
Mann & Whitney test.
Chi-square test
Abbreviations: ISS, Injury Severity Score; SAPS, Simple Acute Physiology Score; SOFA, Sequential Organ Failure Assessment; HLA, Human Leukocyte Antigen; ICU, Intensive Care Unit; D, day; IL, Interleukin.